Erk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ERK2 | ERK2 Protein | MAPK1 | UniProt | 360 aa | 41.3 kDa | Cytoplasm/Nucleus | MAP Kinase Family |
ERK2 Protein is a protein involved in key signaling pathways relevant to neurodegenerative diseases. It plays critical roles in cell survival, synaptic plasticity, and stress response mechanisms that are dysregulated in Alzheimer's disease, Parkinson's disease, and related disorders.
The protein is involved in modulating neuronal function through kinase signaling cascades that regulate gene expression, protein synthesis, and cellular homeostasis.
ERK2 is a 360 aa 41.3 kDa protein belonging to the MAP Kinase Family. The protein contains kinase domain for its enzymatic activity.
MAP kinase, cell proliferation, differentiation, synaptic plasticity. These signaling proteins are critical for transmitting extracellular signals to the nucleus, regulating cell growth, differentiation, survival, and synaptic plasticity.
Alzheimer's Disease: MAPK/ERK pathway is dysregulated in AD brain. AKT signaling is impaired, contributing to tau pathology and neuronal death. PTEN may be overactive.
Parkinson's Disease: MAPK activation contributes to dopaminergic neuron death. AKT signaling is neuroprotective and its impairment may accelerate degeneration.
ALS: Signaling pathways are dysregulated in motor neurons. AKT/PTEN balance is critical for survival.
HD: Mutant huntingtin affects multiple signaling cascades including AKT and MAPK pathways.
The study of Erk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.